Literature DB >> 9292548

In vitro generation of allospecific human CD8+ T cells of Tc1 and Tc2 phenotype.

D C Halverson1, G N Schwartz, C Carter, R E Gress, D H Fowler.   

Abstract

We have previously shown that allospecific murine CD8+ T cells of the Tc1 and Tc2 phenotype could be generated in vitro, and that such functionally defined T-cell subsets mediated a graft-versus-leukemia (GVL) effect with reduced graft-versus-host disease (GVHD). To evaluate whether analogous Tc1 and Tc2 subsets might be generated in humans, CD8+ T cells were allostimulated in the presence of either interleukin-12 (IL-12) and transforming growth factor-beta (TGF-beta) (Tc1 culture) or IL-4 (Tc2 culture). Tc1-type CD8 cells secreted the type I cytokines IL-2 and interferon gamma (IFN-gamma), whereas Tc2-type cells primarily secreted the type II cytokines IL-4, IL-5, and IL-10. Both cytokine-secreting populations effectively lysed tumor targets when stimulated with anti-T-cell receptor (TCR) antibody; allospecificity of Tc1- and Tc2-mediated cytolytic function was demonstrated using bone marrow-derived stimulator cells as targets. In addition, both Tc1 and Tc2 subsets were capable of mediating cytolysis through the fas pathway. We therefore conclude that allospecific human CD8+ T cells of Tc1 and Tc2 phenotype can be generated in vitro, and that these T-cell populations may be important for the mediation and regulation of allogeneic transplantation responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292548

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells.

Authors:  E Liebana; A Aranaz; F E Aldwell; J McNair; S D Neill; A J Smyth; J M Pollock
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

3.  Recycled addition of CD4+ T cell-rich population for induction of human autologous cytotoxic T lymphocytes: A practically efficient method.

Authors:  K Saijo; H Tsurushima; K Tsuboi; T Nose; A Oki; T Ohno
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

4.  Cytokine induction by Streptococcus mutans and pulpal pathogenesis.

Authors:  C L Hahn; A M Best; J G Tew
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.

Authors:  Mark P Rubinstein; Ee Wern Su; Samantha Suriano; Colleen A Cloud; Kristina Andrijauskaite; Pravin Kesarwani; Kristina M Schwartz; Katelyn M Williams; C Bryce Johnson; Mingli Li; Gina M Scurti; Mohamed L Salem; Chrystal M Paulos; Elizabeth Garrett-Mayer; Shikhar Mehrotra; David J Cole
Journal:  Cancer Immunol Immunother       Date:  2015-02-13       Impact factor: 6.968

6.  Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis.

Authors:  E Liébana; R M Girvin; M Welsh; S D Neill; J M Pollock
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Functional characterization of human Tc0, Tc1 and Tc2 CD8+ T cell clones: control of X4 and R5 HIV strain replication.

Authors:  Michèle Février; Sylvie le Borgne; Christian Marty; Antoine Talarmin; Yves Rivière
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

Review 8.  Human CD8+ T Cells in Asthma: Possible Pathways and Roles for NK-Like Subtypes.

Authors:  Olga Lourenço; Ana Mafalda Fonseca; Luis Taborda-Barata
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

9.  Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.

Authors:  M Kohyama; K Saijyo; M Hayasida; T Yasugi; M Kurimoto; T Ohno
Journal:  Jpn J Cancer Res       Date:  1998-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.